{"id":"W2116183806","doi":"10.1016/s1470-2045(12)70567-3","title":"Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; McMaster University","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Carboplatin; Clinical endpoint; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Oncology; Chemotherapy; Endometrial cancer; Gynecologic oncology; Cancer; Clinical trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000773538,0.0002398546,0.001239879,0.00005989023,0.00008585922,0.0000459859,0.0002907976,0.0001215223,0.00173504],"category_scores_gemma":[0.0003343799,0.0001086906,0.00008963954,0.0002366173,0.0001441922,0.00009872023,0.00002636025,0.0002629682,0.00001376655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005912221,"about_ca_system_score_gemma":0.001283158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002945672,"about_ca_topic_score_gemma":0.007036828,"domain_scores_codex":[0.9979135,0.0004194882,0.0006295534,0.0003417157,0.0004227759,0.0002730028],"domain_scores_gemma":[0.9970587,0.001625519,0.0004875196,0.0005433433,0.0001976163,0.0000873093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8768721,0.001242972,0.06046984,0.00001681976,0.001128568,0.00001415258,0.002712234,0.0001110754,0.0003802091,0.000952729,0.003407949,0.05269132],"study_design_scores_gemma":[0.9028552,0.004949276,0.06551111,0.0001316926,0.0001742944,0.000003332083,0.0009459048,0.0002269771,0.0009621893,0.0003310317,0.02373137,0.0001775815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8564069,0.00009550038,0.0001333601,0.1375898,0.0007460686,0.003494916,0.0002293524,0.00003281807,0.00127128],"genre_scores_gemma":[0.9855762,0.0004913788,0.001491489,0.009533488,0.0007809025,0.00181632,0.0000807273,0.00002954721,0.0001999391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1291693,"threshold_uncertainty_score":0.9991775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07110357242492646,"score_gpt":0.4109774263119079,"score_spread":0.3398738538869814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}